Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 5/20 | 0.65 |
| ▸ | CNR1 | P21554 | 1/20 | 0.54 |
| ▸ | CNR2 | P34972 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.43 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.43 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL244867 | 1.00 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL28556041 | 1.00 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL30852876 | 1.00 | FAAH (0.65) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL13044450 | 0.98 | FAAH (0.63) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL27803013 | 0.98 | FAAH (0.63) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL27781446 | 0.95 | FAAH (0.59) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL18597023 | 0.94 | FAAH (0.58) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL7218998 | 0.94 | FAAH (0.63) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL20500708 | 0.93 | FAAH (0.58) | FAAHCNR1CNR2ALDH1A1CA2 | |
| SCHEMBL7217342 | 0.93 | FAAH (0.61) | FAAHCNR1CNR2ALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140271518-A1 | COSMETIC AEROSOL SPRAY WITH LASTING FRESHNESS EFFECT | HENKEL AG & CO. KGAA (DE) | 2014-09-18 | — | — | US | disclosed |
| US-7597881-B2 | Use of ester quats in compositions as sand-repellent substances | GOLDSCHMIDT GMBH (DE) | 2009-10-06 | — | — | US | disclosed |
| US-20070231289-A1 | Use of ester quats in compositions as sand-repellent substances | GOLDSCHMIDT GMBH (DE) | 2007-10-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070231289-A1 | Use of ester quats in compositions as sand-repellent substances | CUTA, DLAT, CRAT | FAAH 105/4885CNR1 2685/4885CNR2 1937/4885 |
| US-20140271518-A1 | COSMETIC AEROSOL SPRAY WITH LASTING FRESHNESS EFFECT | ALOX5, CUTA, OR51E2 | FAAH 67/4885CNR1 370/4885CNR2 871/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.